Literature DB >> 9638138

Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL.

M Matsushita1, M Hijikata, Y Ohta, K Iwata, M Matsumoto, K Nakao, K Kanai, N Yoshida, K Baba, S Mishiro.   

Abstract

We assessed the genetic polymorphism of mannose-binding lectin (MBL) in 93 patients with chronic hepatitis C (45 responders and 48 nonresponders to interferon) and 218 healthy controls. Mutant allele was identified only at codon 54 (Gly-->Asp), leading to three genotypes (54 m/m, 54 W/m, and 54 W/W). Frequency of 54 m/m was significantly lower in interferon-responders (2.2%), compared to those in nonresponders (14.6%) and controls (10.6%): p < 0.05. Our results suggest that homozygous carriage of the variant allele of codon 54 of MBL may predict poor response to interferon in chronic hepatitis C patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638138     DOI: 10.1007/s007050050320

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex.

Authors:  K S Brown; M J Keogh; N Tagiuri; M J Grainge; J S Presanis; S D Ryder; W L Irving; J K Ball; R B Sim; T P Hickling
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome.

Authors:  Z Y Wang; A Morinobu; S Kanagawa; S Kumagai
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 3.  Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.

Authors:  Martine Szyper Kravitz; Milena Pitashny; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

4.  Mannose-binding lectin 2 gene haplotype analysis in Korean patients with ankylosing spondylitis.

Authors:  Churl Hyun Im; Jinhyun Kim; Yun Jong Lee; Eun Young Lee; Eun Bong Lee; Kyung Sook Park; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2011-05-05       Impact factor: 2.631

5.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 6.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population.

Authors:  Jae Youn Cheong; Sung Won Cho; Sun Kyo Lim; Do Hyun Shin; Seung Kew Yoon; Jong Eun Lee; Ki Baik Hahm; Jin Hong Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

8.  Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients.

Authors:  Eirini Koutsounaki; George N Goulielmos; Mary Koulentaki; Christianna Choulaki; Elias Kouroumalis; Emmanouil Galanakis
Journal:  J Clin Immunol       Date:  2008-07-01       Impact factor: 8.317

9.  Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population.

Authors:  Fang-Yu Wang; Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Hiromi Yamashita; Masakatsu Nakamura; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2008-03-27       Impact factor: 3.199

10.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.